Theoretical pharmacokinetic advantages and methodological flaws: glargine is not superior to NPH insulin in children with type 1 diabetes mellitus

dc.creatorDora, José Miguel Silva
dc.creatorScheffel, Rafael Selbach
dc.date2012-05-03T01:26:17Z
dc.date2010
dc.identifier0004-2730
dc.identifierhttp://hdl.handle.net/10183/40073
dc.identifier000755443
dc.formatapplication/pdf
dc.languageeng
dc.relationArquivos brasileiros de endocrinologia & metabologia = Brazilian archives of endocrinology and metabolism. Vol. 54, n. 1 (fev. 2010), p. 82-84
dc.rightsOpen Access
dc.subjectFarmacocinética
dc.subjectInsulina isofana
dc.subjectCriança
dc.subjectMétodos
dc.subjectComplicações
dc.subjectPrevenção e controle
dc.subjectDiabetes mellitus tipo 1
dc.titleTheoretical pharmacokinetic advantages and methodological flaws: glargine is not superior to NPH insulin in children with type 1 diabetes mellitus
dc.typeArtigo de periódico
dc.typeNacional


Este ítem pertenece a la siguiente institución